Marc D. Kozin - Jan 1, 2023 Form 3 Insider Report for Vascular Biogenics Ltd. (VBLT)

Role
Director
Signature
/s/ Samuel Backenroth, Attorney-in-Fact
Stock symbol
VBLT
Transactions as of
Jan 1, 2023
Transactions value $
$0
Form type
3
Date filed
1/3/2023, 08:21 PM
Previous filing
Jun 10, 2022
Next filing
Mar 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VBLT Ordinary Shares 39K Jan 1, 2023 By Marc D. Kozin Irrevocable Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VBLT Stock Option (Right to Buy) Jan 1, 2023 Ordinary Shares 50K $3.30 Direct F2
holding VBLT Stock Option (Right to Buy) Jan 1, 2023 Ordinary Shares 125K $1.17 Direct F3
holding VBLT Stock Option (Right to Buy) Jan 1, 2023 Ordinary Shares 125K $2.38 Direct F4
holding VBLT Stock Option (Right to Buy) Jan 1, 2023 Ordinary Shares 79.4K $2.31 Direct F5
holding VBLT Stock Option (Right to Buy) Jan 1, 2023 Ordinary Shares 52.9K $2.12 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by the Marc D. Kozin Irrevocable Trust, of which the Reporting Person's spouse is one of the beneficiaries. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any.
F2 These options were granted on 05/05/16 under the Issuer's Employee Share Ownership and Option Plan (2014) (the "2014 Plan") and are fully vested and exercisable.
F3 These options were granted on 11/24/20 under the 2014 Plan, with 25% of the shares underlying these options vesting on November 24, 2021 (the one year anniversary of the grant date), and the remainder vesting quarterly thereafter for three years such that they are vested in full on the four-year anniversary of the grant date.
F4 These options were granted on 07/20/21 under the 2014 Plan, with 25% of the shares underlying these options vesting on July 20, 2022 (the one year anniversary of the grant date), and the remainder vesting quarterly thereafter for three years such that they are vested in full on the four-year anniversary of the grant date.
F5 These options were granted on 12/07/21 under the 2014 Plan and vest over two years commencing on the grant date such that 50% vest on the first anniversary of the date of grant and the remainder vest quarterly thereafter for one year such that they are vested in full on the two-year anniversary of the grant date.
F6 These options were granted on 01/02/22 under the 2014 Plan and vest over two years commencing on the grant date such that 50% vest on the first anniversary of the date of grant and the remainder vest quarterly thereafter for one year such that they are vested in full on the two-year anniversary of the grant date.

Remarks:

Exhibit 24 - Power of Attorney